Approximately 8% of DLBCLs harbor IRF8 mutation [n = 244 from 3187 previously reported DLBCL sequences; table S1 (7, 12, 13, 36–41)]. This evidence concerns the gene IRF8 and diffuse large B-cell lymphoma.